Reply to: Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno
Journal of Clinical Oncology · 20.06.2026 · 44 (18) · 1746-1747
DOI: 10.1200/jco-26-00237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.06.2026. Verfasst von Juliet Gray und 3 weiteren Autor:innen. Beteiligte Einrichtung: Juliet Gray, PhD, FRCPCH, Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom; Rebekah Weston, PhD, FRCPCH, and Simo…. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Juliet Gray, PhD, FRCPCH, Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom; Rebekah Weston, PhD, FRCPCH, and Simon Gates, PhD, DIC, FHEA, Cancer Research UK Clinical Trials Unit (CRCT…
ORCID-Profile: Juliet Gray, Rebekah Weston, Lucas Moreno
Zitieren
APA
Gray, J., Weston, R., Gates, S., & Moreno, L. (2026). Reply to: Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno. Journal of Clinical Oncology, 44(18), 1746-1747. https://doi.org/10.1200/jco-26-00237
Vancouver
Gray J, Weston R, Gates S, Moreno L. Reply to: Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno. Journal of Clinical Oncology. 2026;44(18):1746-1747. doi:10.1200/jco-26-00237
BibTeX
@article{Gray2026,
author = {Gray, Juliet and Weston, Rebekah and Gates, Simon and Moreno, Lucas},
title = {Reply to: Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {18},
pages = {1746--1747},
doi = {10.1200/jco-26-00237}
}
EUVIMED